PICC Group-H Forum Takeaways: Life and Health Insurance Growth Is Improving, but the P&C Cycle May Be Near Peak

Overview

This report summarizes the key points from PICC Group-H management discussions at JPMorgan's Asian insurance forum. The core conclusion is that the group's overall value cannot be explained by summing individual businesses. P&C remains the core profit driver, but life and health insurance are increasingly delivering higher growth and incremental value potential. Since PICC P&C's profit share is high and underwriting metrics may be approaching a peak after years of improvement, JPMorgan maintains a Neutral view on the group.

Core views

At the group level, management reaffirmed the current dividend policy and may consider adjusting the dividend base after regulators allow use of an adjusted profit metric that excludes short-term investment volatility. In life insurance, PICC Life's 1Q26 NBV grew 21% year-on-year, with the bancassurance channel targeting double-digit NBV growth in 2026, while the agency channel is expected to grow faster, supported by longer-duration, higher-margin products and improving agent capacity. In health insurance, PICC Health's scale is broadly comparable with PICC Life, and profitability has improved amid aging demographics and rising healthcare spending. In P&C, the company wants motor premium growth to outpace the industry, non-motor growth to reach or exceed GDP growth, and the combined ratio to continue improving over the next two to three years, but the report believes further underwriting-cycle improvement may be limited.

Analysis framework

The report combines conference minutes with fundamental judgment by linking management disclosures on dividends, channels, product mix, NBV, net profit, combined ratio, and new-energy vehicle underwriting trends with JPMorgan's views on the non-life cycle, life insurance recovery, and health insurance profitability to derive the rating and target price.

Methodology notes

• Valuation methodsSOTP

  Sum-of-the-parts valuation

  The target price is based on segment valuation: PICC P&C at 8.0x FY26E P/E, PICC Life at 3.0x P/E, and PICC Health at 1.5x P/E, summed to a Dec 2026 target price of HK$5.8.

• Insurance operating metricsNBV

  New Business Value

  The report uses NBV to gauge the quality and growth of new business in life and health insurance. PICC Life's 1Q26 NBV grew 21% year-on-year, with future product-mix improvement as an important watch point.

• Insurance underwriting metricsCombined Ratio

  Combined ratio

  Combined ratio is used to measure P&C underwriting profitability. In 2025, PICC P&C's motor, non-motor, and full combined ratios were 95.3%, 100.8%, and 97.5%, respectively.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• PICC Group-H (1339.HK)

  Target coverage

  Strengths

  It has core subsidiaries including PICC P&C, PICC Life, and PICC Health, a clear dividend policy, and growth potential in health and life insurance.

  Weaknesses

  Profitability is heavily dependent on PICC P&C, while further improvement in life insurance operating metrics may be nearing a peak.

  Comparison

  Compared with single-line P&C or life insurers, the group's value reflects a combination of P&C cash flow with life and health insurance growth.

  Risks

  P&C underwriting-cycle deterioration, slower-than-expected life insurance sales recovery, and slower-than-expected product mix improvement.

• PICC P&C

  Core profit source and main SOTP component

  Strengths

  Contributes about 80% of group profits, with a 2025 overall combined ratio of 97.5%; private-sector new-energy vehicle combined ratio has been below 100% for many years.

  Weaknesses

  Non-motor combined ratio is 100.8%; new-energy vehicle compulsory and commercial combined ratios remain above 100%, and underwriting improvement may be limited.

  Comparison

  Applied at 8.0x FY26E P/E in the SOTP framework, above the multiples of life and health insurance components.

  Risks

  Non-life underwriting cycle could deteriorate faster than expected, resulting in weaker-than-expected profit growth.

• PICC Life

  Source of life insurance growth and transition

  Strengths

  1Q26 NBV rose 21% year-over-year, and the agency channel is expected to benefit from longer-duration, higher-margin products and higher agent productivity.

  Weaknesses

  The share of participating policies is high, and while rate sensitivity is lower, overall profitability is also relatively low.

  Comparison

  In 2025, NBV and net profit were higher than PICC Health, but the gap has narrowed considerably.

  Risks

  Insufficient progress in protection products, weak control of standalone savings-style policy sales, and slower-than-expected recovery in life insurance sales.

• PICC Health

  Health insurance growth component

  Strengths

  Profitability has improved amid aging demographics and rising medical spending, with 2025 NBV and net profit of RMB 73 billion and RMB 82 billion, respectively.

  Weaknesses

  Disclosed valuation multiples are lower than PICC P&C and PICC Life, suggesting the market may still apply conservative pricing.

  Comparison

  1Q26 net profit of RMB 19.65 billion is now broadly close to PICC Life's RMB 19.62 billion.

  Risks

  Changes in healthcare spending, claims ratio, regulatory policy, and product pricing could affect profit sustainability.

Key data

• RatingNeutralJPMorgan maintains a Neutral view on PICC Group-H.
• Target PriceHK$5.8Target price through Dec 2026, based on SOTP valuation.
• PICC P&C Profit Contributionabout 80%The report notes a high contribution of non-life insurance profits, but underwriting metrics may be near a peak.
• PICC Life 1Q26 NBV Growth21% year-over-yearThe share of participating policies is relatively high, and it will place more emphasis on protection products that better thicken NBV going forward.
• PICC Health 2025 NBVRMB 73 billionClose to PICC Life's RMB 82 billion.
• PICC Health 2025 Net ProfitRMB 82 billionPICC Life's corresponding net profit was RMB 115 billion.
• PICC Health 1Q26 Net ProfitRMB 19.65 billionGenerally close to PICC Life's RMB 19.62 billion.
• PICC P&C 2025 Combined RatioOverall 97.5%; motor 95.3%; non-motor 100.8%The company targets further improvement over the next two to three years.
• New-Energy Vehicle Claims Ratio Change1Q26 down by 3 percentage pointsDriven by lower accident frequency, but compulsory and commercial new-energy vehicle combined ratios remain above 100%.

Impact & implications

For investors, the main implication of the report is that PICC Group-H's near-term valuation support comes from dividends, P&C profits, and SOTP valuation, while further upside depends on improvements in life insurance product mix, life insurance sales recovery, and a slower-than-expected deterioration in the P&C underwriting cycle. If life and health insurance profit contributions continue to expand, the group's value profile could improve. If the P&C cycle weakens more quickly, the high-profit-share business will drag on group performance.

Risks

• Upside risk includes faster-than-expected product mix improvement and better control of standalone savings-type policy sales.
• Upside risk includes stronger-than-expected profit growth from PICC P&C, potentially because non-life insurance underwriting-cycle deterioration is slower than expected.
• Upside risk includes better-than-expected recovery in life insurance sales.
• Downside risk includes slower-than-expected product mix improvement and insufficient control of standalone savings-type policy sales.
• Downside risk includes weaker-than-expected PICC P&C profit growth, potentially because non-life underwriting-cycle deterioration is faster than expected.
• Downside risk includes slower-than-expected recovery in life insurance sales.

What to watch

• Whether regulators will allow an adjusted profit metric excluding short-term investment volatility to be used as the dividend-policy basis.
• The share of protection products and NBV growth in PICC Life in subsequent quarters.
• The divergence in NBV growth between bancassurance and agency channels and improvements in agency productivity.
• Whether PICC Health's net profit and NBV can continue to approach or exceed PICC Life.
• Changes in PICC P&C combined ratios for motor, non-motor, and new-energy vehicles.
• Whether agricultural insurance can maintain slight long-term profitability or break-even.